Wilbanks Smith & Thomas Asset Management’s ProShares Ultra NASDAQ Biotechnology BIB Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Shares Change %	Capital Flow	Portfolio Weight	Portfolio Position
2017 Q3	–	Sell	-4,330	Closed	-$231K	–	340
2017 Q2	$231K	Buy	+4,330	New	+$231K	0.02%	282
2015 Q4	–	Sell	-8,140	Closed	-$474K	–	282
2015 Q3	$474K	Buy	+8,140	New	+$474K	0.07%	151